期刊文献+

CT引导术中实时计划对胸部肿瘤^125I粒子植入治疗的价值 被引量:35

The study of intraoperative real-time planning by CT-guided in 125I seed implantation for thoracic malignancie
原文传递
导出
摘要 目的探讨CT引导下计算机三维治疗计划系统(TPS)术中实时治疗计划在^125I粒子植入治疗胸部肿瘤中应用的必要性和可行性。方法对2010-2012年间31例行^125I粒子治疗的胸部肿瘤患者资料进行回顾分析,其中13例术中行TPS实时计划优化(A组),余18例未行术中实时计划(B组)。按经验间隔1cm植入粒子,所有患者处方剂量110Gy,术后均行TPS质量验证。并在B组原术中影像资料上重新模拟实时计划(C组),比较各组质量验证满意率。采用x^2检验差异。结果A、B组术后质量验证满意率分别为92%、39%(P=0.003),C组重新模拟计划后满意率为94%,也高于B组(P=0.001),但与A组相似(P=0.811)。结论术中实时治疗计划在CT引导下^125I粒子治疗胸部肿瘤可显著提高肿瘤靶区剂量满意率,具有可操作性,对胸部肿瘤粒子治疗的规范化具有重要价值。 Objective To explore the necessity and feasibility of the real-time treatment planning optimization by CT guided with 125I seed implantation brachytherapy treatment to thoracic malignancies. Methods To retrospectively analyze the data of 31 inpatients (from October 2010 to June 2012) with thoracic malignancie by CT guidance 125I brachytherapy. The real-time planning optimization were applicated to 13 cases (group A), 18 patients undergoing experience particles implantation interval 1 cm (group B), all the patients were prescribed dose 110 Gy and post-planning verified after surgery. Re-simulation of real- time program (group C) about the image data in group B, data analysis was x2-test by SPSS 13.0 software. Results The quality verification in two groups were 92% and 39%, the difference was statistically sifnificant (P = 0. 003 ). The re-simulation program in group C was 94% , there was significant difference compared with group B ( P = 0. 001 ) , but with no significant difference compared with group A ( P = 0. 811 ). Conclusions The application of intraoperative real-time planning by CT guided with ^125I seed implantation braehytherapy to thoraeic malignancies, non-equidistant layout that be the real implantedneedle trajectory based on dosimetry, can significantly improve the tumor target dose, operational, there was greatly important value to the standardization of the particle therapy of thoracic malignancies.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2013年第5期400-403,共4页 Chinese Journal of Radiation Oncology
关键词 胸部肿瘤 近距离疗法 碘-125粒子 术中实时治疗计划 Thoracic neoplasms/brachytherapy Iodine-125 seed Intraoperative real-time planning
  • 相关文献

参考文献11

  • 1Trombetta MG, Colonias A, Makishi D, et al. Tolerance of the aorta using intraoperative Iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy,2008 ,7 :50-54.
  • 2Wang J, Jiang Y, Li J, et al. [ntraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma. J Exp Clin Cancer Res,2009,28:88.
  • 3Older RA, Synder B, Krupski TL, et al. Radioactive implant migration inpatients treated for localized prostale cancer with interstitial brachytherapy. J Urol,2001,165 : 1590-1592.
  • 4Lee W, Daly BD, DiPetriUo TA, et al. Limited resection for non- small cell lung cancer:observed local control with implantation of 1-125 brachytherapy seeds. Ann Thorac Surg,2003 ,75 :237-243.
  • 5Darakchiev B J, Albright RE, Breneman JC, et al. Safety andefficacy of permanent iodine-125 seed implants andcarmustine wafers in patients with recurrent glioblastoma multiforme. Neumsurg,2008,108 : 236 -242.
  • 6Nag S, Bice WS, Degaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys, 2000,46:221-230.
  • 7申文江.放射性粒子植入的临床应用//柴树德,郑广钧,王俊杰,等.放射性粒子植入治疗胸部肿瘤.北京:人民卫生出版社,2012:8-9.
  • 8Lee EK, Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys,2003, 56:854-861.
  • 9王娟,王绍其,徐建彬,杨华,徐丽君,公维宏,靳妍霞.^125I粒子不同分布组织间植入对荷人胃癌裸鼠移植瘤疗效的影响[J].中华核医学杂志,2008,28(5):313-316. 被引量:11
  • 10王俊杰,田素青,李金娜,刘江平,姜伟娟.放射性^(125)I粒子平面永久插植布源剂量分布研究[J].中国微创外科杂志,2005,5(12):1061-1062. 被引量:18

二级参考文献22

  • 1田志远,左书耀,王叙馥,王国明,张勤.^(125)Ⅰ粒子组织间植入对小鼠移植性肝细胞癌的治疗作用[J].中华核医学杂志,2006,26(3):174-176. 被引量:2
  • 2Pommier P, Villers A, Bataillard A, et al. Standards, options,and recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity. Cancer Radiother, 2001, 5 : 770- 786.
  • 3Ragde H, Grado GL, Nadir BS. Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol, 2001, 54: 739-747.
  • 4Wheeler JM, Warren BF, Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation : a proposal for a modified staging system. Dis Colon Rectum, 2002, 45: 1051- 1056.
  • 5Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer(EORTC). Int J Radiat Oncol Biol Phys, 1995, 31: 1341-1346.
  • 6Reniers B, Verhaegen F, Vynckier S. The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements. Phys Med Biol, 2004, 49: 1569- 1582.
  • 7Lee PC,Parks EK,Moran BJ.An innovative dosimetric model for formulating a semi-analytical solution for the activity-volume relationship in prostate implants.Med Dosim,2003,28:243-253.
  • 8Sureka CS,Sunny CS,Subbaiah KV,et al.Dose distribution for endovascular brachytherapy using 192Ir sources:comparison of Monte Carlo calculations with radiochromic film measurements.Phys Med Biol,2007,52:525-537.
  • 9Pinkawa M,Gagel B,Asadpour B,et al.Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.Strahlenther Onkol,2008,184:520-525.
  • 10Su Y,Davis BJ,Furutani KM,et al.Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy:increased seed number correlates with less variability in prostate dosimetry.Phys Med Biol,2007,52:3105-3119.

共引文献24

同被引文献180

引证文献35

二级引证文献209

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部